French spend heavily on devices and analyses:
This article was originally published in Clinica
Executive Summary
Estimates for 2001 indicate that French spending on medical devices and materials used in the private sector and featuring on a list of products reimbursed by the state (formerly known as the TIPS list) increased by 13.8% over 2000. Spending on clinical analyses, meanwhile, was up by 6%. These are among the highest increases within the healthcare service and are likely to mean that there are more cost-containment measures on the horizon.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.